Frankfurt
21.08.25 | 09:59
0,202 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.08. | LEE'S PHARM (00950): NOTICE OF BOARD MEETING | 2 | HKEx | ||
| 31.07. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - UPDATE ON AN INVESTIGATIONAL ONCOLOGY DRUG PRODUCT | 2 | HKEx | ||
| LEES PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 22.05. | LEE'S PHARM (00950): ANNUAL GENERAL MEETING HELD ON 22 MAY 2025 - POLL RESULTS | 1 | HKEx | ||
| 24.04. | LEE'S PHARM (00950): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
| 24.04. | LEE'S PHARM (00950): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | 2 | HKEx | ||
| 23.04. | LEE'S PHARM (00950): PROXY FORM | 1 | HKEx | ||
| 23.04. | LEE'S PHARM (00950): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024 | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): ANNUAL REPORT 2024 | - | HKEx | ||
| 27.03. | LEE'S PHARM (00950): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 | 1 | HKEx | ||
| 27.03. | LEE'S PHARM (00950): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 | - | HKEx | ||
| 19.03. | LEE'S PHARM (00950): POSITIVE PROFIT ALERT | 3 | HKEx | ||
| 12.03. | LEE'S PHARM (00950): NOTICE OF BOARD MEETING | 2 | HKEx | ||
| 12.09.24 | Dividendenbekanntmachungen (12.09.2024) | 10.203 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,7 USD EUR AIR NEW ZEALAND LIMITED NZAIRE0001S2 0,015 NZD 0,0083 EUR ALAMOS GOLD INC CA0115321089 0... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 99,99 | -0,11 % | Gilead Sciences Gains In Vivo Cell Therapy Capability With $350M Interius Bio Acquisition | ||
| ZOETIS | 135,16 | +0,82 % | Zoetis platziert Anleihen im Volumen von 1,85 Milliarden US-Dollar | ||
| SINOPHARM | 2,137 | -1,34 % | SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL UNAUDITED FINANCIAL DATA OF CNMDC FOR THE SIX MONTHS ENDED 30 JUNE 2025 | ||
| CSPC PHARMA | 1,132 | 0,00 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - DUPILUMAB INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA | ||
| WUXI BIOLOGICS | 3,559 | +3,05 % | WuXi Biologics Reports Solid 2025 Interim Results | Revenue increased by 16.1% YoY to RMB 9,953.2 million; revenue growth from continuing operations was 20.2%
IFRS Gross profit margin expanded by 3.6% YoY to 42.7%
... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,248 | 0,00 % | Dividendenbekanntmachungen (24.07.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) APTARGROUP INC US0383361039 0,45 USD 0,3823 EUR BLOOMSBURY PUBLISHING PLC GB0033147751 0,1154 GBP 0,1331 EUR CALNEX SOLUTIONS PLC GB00BMBK7016 0... ► Artikel lesen | |
| GEDEON RICHTER | 26,660 | 0,00 % | Gedeon Richter Plc.: Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life - Gedeon Richter at the World Congress on Endometriosis | SYDNEY, May 28, 2025 /PRNewswire/ --
Gedeon Richter had a strong presence at the World Congress of Endometriosis held this year in Sydney, Australia between 21-24 May 2025. As a Platinum... ► Artikel lesen | |
| DR REDDYS | 12,100 | +0,83 % | Extrovis AG and Dr. Reddy's announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. | Extrovis AGBahnhof Park 46340, Baar, SwitzerlandMedia Relations ContactMadhu Marurmadhu.marur@extrovis.com (mailto:madhu.marur@extrovis.com)
... ► Artikel lesen | |
| MEDIPHARM LABS | 0,045 | -5,81 % | Schreiner MediPharm & Bluesight Introduce RFID-Based Inventory Solution | ||
| ASPEN PHARMACARE | 5,350 | +1,90 % | ASPEN PHARMACARE HOLDINGS LIMITED - Business Update and Trading Statement for the Financial year ended 30 June 2025 | ||
| SHANGHAI PHARMACEUTICALS | 1,440 | +3,60 % | SH PHARMA (02607): NOTICE OF BOARD MEETING | ||
| LUYE PHARMA | 0,402 | 0,00 % | LUYE PHARMA (02186): NOTICE OF BOARD MEETING | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,160 | -1,23 % | SIHUAN PHARM (00460): NOTICE OF BOARD MEETING | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,555 | 0,00 % | CHINARES PHARMA (03320): ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF DONG-E-E-JIAO FOR THE SIX MONTHS ENDED 30 JUNE 2025 | ||
| HANSOH PHARMACEUTICAL | 4,120 | 0,00 % | CLSA Lifts TPs for HANSOH PHARMA, CMS on Expectations of Continued Growth for Pharmas |
Das Unternehmen LEES PHARMACEUTICAL HOLDINGS LTD kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,202 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LEES PHARMACEUTICAL HOLDINGS LTD finden Sie auf Wallstreet Online.